Zobrazeno 31 - 40
of 261
pro vyhledávání: ''
Autor:
Xiang-Yun Yan, Jun-Peng Yao, Yan-Qiu Li, Xian-Jun Xiao, Wan-Qing Yang, Si-Jue Chen, Tai-Chun Tang, Yu-Qing Yang, Liu Qu, Yu-Jun Hou, Min Chen, Ying Li
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Objective: To comprehensively evaluate the effect of acupuncture on gut microbiota, identify specific microbes closely related to the clinical efficacy of acupuncture, and explored the role of short-chain fatty acids (SCFAs).Methods: A randomized pla
Externí odkaz:
https://doaj.org/article/63c446f03a634f96a28f56506d02f66c
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Atherosclerosis (AS) is a chronic inflammatory reaction that primarily affects large and medium-sized arteries. It is a major cause of cardiovascular disease and peripheral arterial occlusive disease. The pathogenesis of AS involves specific structur
Externí odkaz:
https://doaj.org/article/32659d3a6ae444caa23c3ff533860427
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
The human gut microbiota is a complex ecosystem regulating the host’s environmental interaction. The same functional food or drug may have varying bioavailability and distinct effects on different individuals. Drugs such as antibiotics can alter th
Externí odkaz:
https://doaj.org/article/7cee0a987758450db0d61f1bafd9e9f9
Autor:
Sehyeon Jang, San Kim, Bo Ram So, Younghoon Kim, Chang-Kil Kim, Jeong Jae Lee, Sung Keun Jung
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Although sinapic acid is found in various edible plants and has been shown to have anti-inflammatory properties including colitis, its underlying mechanism and effects on the composition of the gut microbiota are largely unknown. We aim
Externí odkaz:
https://doaj.org/article/5b13969a68c148ada6e4ca17f4335e18
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Ulcerative colitis (UC) is a chronic inflammatory bowel disorder of the large intestine. Previous studies have indicated that the gut microbiota plays an important role in the triggers, development, and treatment response of UC. Natural active molecu
Externí odkaz:
https://doaj.org/article/01039071288b49d9bc050c8979ff1346
Autor:
Yifan Feng, Chenyang Wu, Huan Chen, Tingting Zheng, Hanyi Ye, Jinrui Wang, Yinghua Zhang, Jia Gao, Ying Li, Zhengqi Dong
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Inflammatory bowel disease (IBD) affects about 7 million people globally, which is a chronic inflammatory condition of the gastrointestinal tract caused by gut microbiota alterations, immune dysregulation, genetic and environmental fact
Externí odkaz:
https://doaj.org/article/fd82285a67df4f338291a4b300e3a005
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: The microbiota–gut–brain axis has been proposed as a potential therapeutic target of PD. The effects of curcumin against Parkinson’s disease have been demonstrated; however, its neuroprotective mechanisms remain unknown. Our study i
Externí odkaz:
https://doaj.org/article/dd105c8d5b5643bbbda25cff21f4b0b6
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Polysaccharides from Grifola frondosa (Dicks.) Gray (HSH) and Inonotus obliquus (Fr.) Pilat (BHR) showed noticeable effects on dextran sulfate sodium (DSS)-induced colitis, but their systemic modulation effects have not been fully revea
Externí odkaz:
https://doaj.org/article/4df362c83b1f424ea4e2612851b0ad63
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Chronic low-grade inflammation affects health and is associated with aging and age-related diseases. Dysregulation of the gut flora is an important trigger for chronic low-grade inflammation. Changes in the composition of the gut flora and exposure t
Externí odkaz:
https://doaj.org/article/8d4bdd5ec9ce46608cbbeef064f7c42a
Autor:
Hai-Jun Li, Dan-Qing Li, Yu-Liang Zhang, Xiao-Fei Ding, Hai-Tao Gao, Ya Zhu, Jun Liu, Li-Xia Zhang, Jie Chen, Guang Chen, Ying Yu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Gut microbiota affects the gut–brain axis; hence, the modulation of the microbiota has been proposed as a potential therapeutic strategy for cerebral ischemia/reperfusion injury (CIRI). However, the role and mechanism of the gut microbiota in regul
Externí odkaz:
https://doaj.org/article/3ba6917b54714947a817a5f299585aa7